A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
Huifang Zong(Shanghai Jiao Tong University), Jianwei Zhu(Quzhou University)
Cited by 29
Related Papers
Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer
|Journal of Nanobiotechnology|2022|66
A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer
|Journal of Experimental & Clinical Cancer Research|2020|62